New RSV Vaccines Could Change Cold Season

There are three RSV vaccines for adults that are in phase 3 trials, and two more candidates in early stages of development.

Screen Shot 2022 04 18 At 2 43 12 Pm
Getty Images

Respiratory syncytial virus, also known as RSV, creates cold-like symptoms but can lead to much more serious issues such as severe lung inflammation or infection. Each year tens of thousands of kids are hospitalized for RSV, and hundreds die, and those numbers are on the rise. For example, babies under twelve months old are being hospitalized at a rate six times higher than three years ago. A recent Vox article discussed vaccines for said virus and how they could fundamentally change cold season.

FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report